Pinsent Masons appoints Michael Finn as partner in Dublin

Gayle Bowen
Gayle Bowen

Pinsent Masons has announced the appointment of life sciences and technology litigation specialist Michael Finn as a partner in Dublin.

Mr Finn will join the firm from Matheson, where he currently leads its IP disputes group and previously established its life sciences regulatory and litigation practice.

He will work alongside IP and data litigation specialist Ann Henry to enhance Pinsent Mason’s big pharma offering in Dublin.

Clare Tunstall, head of life sciences at Pinsent Masons, said: “We are continuing to invest in appointing talented individuals who bolster our ability to service our international client base.

“Pinsent Masons has a pan European team of lawyers specialising in life sciences and healthcare who advise across a range of IP, transactional and regulatory matters and Michael’s stellar reputation and experience makes him a fantastic addition to our team.”

Gayle Bowen, head of Pinsent Masons’ Dublin office, added: “Michael is a recognised leading practitioner who brings sector knowledge and expertise that is unmatched in the Irish market.

“His diverse experience complements Pinsent Masons’ international advanced manufacturing and technology sector and is a valuable addition to our Dublin office.”

Michael’s appointment continues the expansion of Pinsent Masons’ Dublin office, and follows the firm’s recent recruitment of corporate financial services partner Naoise Harnett.

Pinsent Masons now boasts a partner count of nine in Dublin, tripled from three in just two years.

Related posts